Publications

A Complete list of our publications is here (Link to PubMed, might be inaccurate).

 

2021

Drozdovitch V, Minenko V, Kukhta T, Viarenich K, Trofimik S, Rogounovitch T, Nakayama T, Drozd V, Veyalkin I, Mitsutake N, Ostroumova E, Saenko V.

Thyroid dose estimates for the genome-wide association study of thyroid cancer in persons exposed in Belarus to 131I after the Chernobyl accident.

J Radiat Res, 2021 Sep Epub [PubMed]

Nakao T, Matsue M, Saenko V, Rogounovitch T, Tanaka A, Suzuki K, Higuchi M, Sasai H, Sano T, Hirokawa M, Miyauchi A, Kawakami A, Mitsutake N.

Preoperative detection of the TERT promoter mutations in papillary thyroid carcinomas.

Clin Endocrinol, 2021 Jul Epub [PubMed]

Rogounovitch TI, Mankovskaya SV, Fridman MV, Leonova TA, Kondratovitch VA, Konoplya NE, Yamashita S, Mitsutake N, Saenko VA.

Major Oncogenic Drivers and Their Clinicopathological Correlations in Sporadic Childhood Papillary Thyroid Carcinoma in Belarus.

Cancers, 13: 3374, 2021 [PubMed]

Kawamura K, Suzuki K, Mitsutake N.

Technical Report: A Simple and Robust Real-Time Quantitative PCR Method for the Detection of Radiation-Induced Multiple Exon Deletions of the Human HPRT Gene.

Radiet Res, 2021 Jun Epub [PubMed]

Amrenova A, Suzuki K, Saenko V, Yamashita S, Mitsutake N.

Cell competition between anaplastic thyroid cancer and normal thyroid follicular cells exerts reciprocal stress response defining tumor suppressive effects of normal epithelial tissue.

PLoS One, 16: e0249059, 2021 [PubMed]

Suzuki K, Amrenova A, Mitsutake N.

Recent advances in radiobiology with respect to pleiotropic aspects of tissue reaction.

J Radiat Res, 62(Suppl_1): i30-i35, 2021 [PubMed]

Mitsutake N, Saenko V.

Molecular pathogenesis of pediatric thyroid carcinoma.

J Radiat Res, 62(Suppl_1): i71-i77, 2021 [PubMed]

2020

Bogdanova TI, Saenko VA, Hashimoto Y, Hirokawa M, Zurnadzhy LY, Hayashi T, Ito M, Iwadate M, Mitsutake N, Rogounovitch TI, Sakamoto A, Naganuma H, Miyauchi A, Tronko MD, Thomas G, Yamashita S, Suzuki S.

Papillary Thyroid Carcinoma in Ukraine After Chernobyl and in Japan After Fukushima: Different Histopathological Scenarios.

Thyroid, 2020 Aug Epub [PubMed]

Iwadate M, Mitsutake N, Matsuse M, Fukushima T, Suzuki S, Matsumoto Y, Ookouchi C, Mizunuma H, Nakamura I, Nakano K, Sakamoto A, Hirokawa M, Ito M, Naganuma H, Hashimoto Y, Shimura H, Yamashita S, Suzuki S.

The clinicopathological results of thyroid cancer with BRAFV600E mutation in the young population of Fukushima.

J Clin Endocrinol Metab, 105: dgaa573, 2020 [PubMed]

2019

Suzuki K, Akita S, Yoshimoto H, Ohtsuru A, Hirano A, Yamashita S.

Biological Features Implies Potential Use of Autologous Adipose-Derived Stem/Progenitor Cells in Wound Repair and Regenerations for the Patients with Lipodystrophy.

Int J Mol Sci, 20: 5505, 2019 [PubMed]

Suzuki K, Saenko V, Yamashita S, Mitsutake N.

Radiation-Induced Thyroid Cancers: Overview of Molecular Signatures.

Cancers, 11: 1290, 2019 Review [PubMed]

Tanaka A, Matsuse M, Saenko V, Nakao T, Yamanouchi K, Sakimura C, Yano H, Nishihara E, Hirokawa M, Suzuki K, Miyauchi A, Eguchi S, Yoshiura KI, Yamashita S, Nagayasu T, Mitsutake N.

TERT mRNA Expression as a Novel Prognostic Marker in Papillary Thyroid Carcinomas.

Thyroid, 29: 1105-1114, 2019 [PubMed]

Meng Z, Matsuse M, Saenko V, Yamashita S, Ren P, Zheng X, Jia Q, Tan J, Li N, Zheng W, Zhao L, Mitsutake N.

TERT promoter mutation in primary papillary thyroid carcinoma lesions predicts absent or lower 131 i uptake in metastases.

IUBMB Life, 71: 1030-1040, 2019 [PubMed]

Saijo H, Suzuki K, Yoshimoto H, Imamura Y, Yamashita S, Tanaka K.

Paracrine Effects of Adipose-Derived Stem Cell Promote Lymphangiogenesis in Irradiated Lymphatic Endothelial Cells.

Plast Reconstr, 143: 1189e-1200e, 2019 [PubMed]

Shiraiwa K, Matsuse M, Nakazawa Y, Ogi T, Suzuki K, Saenko V, Xu S, Umezawa K, Yamashita S, Tsukamoto K, Mitsutake N.

JAK/STAT3 and NF-κB Signaling Pathways Regulate Cancer Stem-Cell Properties in Anaplastic Thyroid Cancer Cells.

Thyroid, 29: 674-682, 2019 [PubMed]

Suzuki S, Bogdanova TI, Saenko VA, Hashimoto Y, Ito M, Iwadate M, Rogounovitch TI, Tronko MD, Yamashita S.

Histopathological analysis of papillary thyroid carcinoma detected during ultrasound screening examinations in Fukushima.

Cancer Sci, 110: 127-133, 2019 [PubMed]

2018

Bogdanova TI, Saenko VA, Brenner AV, Zurnadzhy LY, Rogounovitch TI, Likhtarov IA, Masiuk SV, Kovgan LM, Shpak VM, Thomas GA, Chanock SJ, Mabuchi K, Tronko MD, Yamashita S.

Comparative Histopathologic Analysis of "Radiogenic" and "Sporadic" Papillary Thyroid Carcinoma: Patients Born Before and After the Chernobyl Accident.

Thyroid, 28: 880-890, 2018 [PubMed]

Todorović L, Stanojević B, Mandušić V, Petrović N, Živaljević V, Paunović I, Diklić A, Saenko V, Yamashita S.

Expression of VHL tumor suppressor mRNA and miR-92a in papillary thyroid carcinoma and their correlation with clinical and pathological parameters.

Med Oncol, 35: 17, 2018 [PubMed]

Yamashita S, Suzuki S, Suzuki S, Shimura H, Saenko V.

Lessons from Fukushima: Latest Findings of Thyroid Cancer After the Fukushima Nuclear Power Plant Accident.

Tyroid, 28: 11-22, 2018 [PubMed]

2017

Khvostunov IK, Saenko VA, Krylov V, Rodichev A, Yamashita S

Cytogenetic biodosimetry and dose-rate effect after radioiodine therapy for thyroid cancer

Radiat Environ Biophys, 56: 213-226, 2017 [PubMed]

Suzuki K

Analyzing ATM Function by Electroporation of Endonucleases and Immunofluorescence Microscopy

Methods Mol Biol, 1599: 85-96, 2017 [PubMed]

Iyama K, Matsuse M, Mitsutake N, Rogounovitch T, Saenko VA, Suzuki K, Ashizawa M, Ookouchi C, Suzuki S, Mizunuma H, Fukushima T, Suzuki S, Yamashita S

Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET in Thyroid Cancers of Young Patients in Fukushima

Thyroid, 27: 811-818, 2017 [PubMed]

Yamashita S, Saenko V

What Is the "Screening Effect" Six Years After the Fukushima Nuclear Power Plant Accident?

Thyroid, 27: 595-596, 2017[PubMed]

Matsuse M, Yabuta T, Saenko V, Hirokawa M, Nishihara E, Suzuki K, Yamashita S, Miyauchi A, Mitsutake N

TERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independent factors

Sci Rep, 7: 41752, 2017 [PubMed]

Nikitski A, Rogounovitch T, Bychkov A, Takahashi M, Yoshiura KI, Mitsutake N, Kawaguchi T, Matsuse M, Drozd VM, Demidchik YE, Nishihara E, Hirokawa M, Miyauchi A, Rubanovich AV, Matsuda F, Yamashita S, Saenko VA

Genotype analyses in the Japanese and Belarusian populations reveal independent effects of rs965513 and rs1867277 but do not support the role of FOXE1 polyalanine tract length in conferring risk for papillary thyroid carcinoma

Thyroid, 27: 224-235, 2017 [PubMed]